TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)
$0.095 0.034799 (57.8047%)
Analysed TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) News Sources
Is Estrella Immunopharma (NASDAQ:ESLA) In A Good Position To Deliver On Growth Plans?
14-08-2025
yahoo.com
Top 100 Stocks to Buy: Two Penny Stocks Moved Up 51 Spots. Should You Buy Either?
04-11-2025
barchart.com
ESLA: Initiating Coverage of Estrella Immunopharma: A Potential Successor to Arcellx in Next-Generation CAR-T
18-03-2026
yahoo.com
ESLA: Can Next-Generation CAR-T Therapy Improve Disease Control in Extranodal Lymphoma?
14-07-2026
yahoo.com
Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma
24-07-2026
yahoo.com
Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
29-07-2026
yahoo.com
What is the current price of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)?
The current price of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) is $0.095.
TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) since the previous trading day is $0.034799.
TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) since the previous trading day is 57.8047%.
What is the most recent average sentiment score for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)?
The most recent average sentiment score for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)?
The most recent sentiment for TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ) is .
SEC-8K** Filing Available For TRADEUP ACQUISITION CORP-CW (ESLAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.